MedPath

Potassium citrate

Generic Name
Potassium citrate
Brand Names
Cytra-K, Urocit-K
Drug Type
Small Molecule
Chemical Formula
C6H5K3O7
CAS Number
866-84-2
Unique Ingredient Identifier
86R1NVR0HW
Background

Potassium citrate (also known as tripotassium citrate) is a potassium salt of citric acid. It is a white, hygroscopic crystalline powder. It is odorless with a saline taste. It contains 38.3% potassium by mass. In the monohydrate form it is highly hygroscopic and deliquescent.

Potassium citrate is used to treat a kidney stone condition called renal tubular acidosis. Potassium Citrate is indicated also for the management of Hypocitraturic calcium oxalate nephrolithiasis.

Indication

For the management of renal tubular acidosis, hypocitraturic calcium oxalate nephrolithiasis, and uric acid lithiasis with or without calcium stones.

Associated Conditions
Bowel preparation therapy, Constipation, Hypocitraturic calcium oxalate nephrolithiasis, Kidney Stones, Metabolic Acidosis, Renal tubular acidosis, Uremia, Uric Acid Nephrolithiasis, Chronic metabolic acidosis
Associated Therapies
Laxative

Metabolic Acidosis in Renal Transplant Patients

Phase 2
Completed
Conditions
Renal Transplant Patients
Metabolic Acidosis
Physical Capacity
Bone Disease
Mineral Metabolism
Interventions
First Posted Date
2009-06-04
Last Posted Date
2010-10-22
Lead Sponsor
University of Zurich
Target Recruit Count
30
Registration Number
NCT00913796
Locations
🇨🇭

University Hospital of Zurich, Zurich, Switzerland

Effect of Neutralization of Endogenous Acid Production on BMD and Bone Microarchitectural

Phase 3
Completed
Conditions
Healthy
Interventions
First Posted Date
2007-07-31
Last Posted Date
2012-04-24
Lead Sponsor
Kantonsspital Baselland Bruderholz
Target Recruit Count
202
Registration Number
NCT00509405
Locations
🇨🇭

Department of Medicine, Kantonsspital Bruderholz, Bruderholz/Basel, BL, Switzerland

The Effects of Potassium Citrate on Bone Metabolism

Phase 4
Completed
Conditions
Osteoporosis, Postmenopausal
Bone Diseases, Metabolic
Interventions
First Posted Date
2006-07-27
Last Posted Date
2017-06-12
Lead Sponsor
Weill Medical College of Cornell University
Target Recruit Count
83
Registration Number
NCT00357331
Locations
🇺🇸

Weill Cornell Medical College, New York, New York, United States

Effects of Potassium Citrate in Urine of Children With Elevated Calcium in Urine and Kidney Stones

Not Applicable
Withdrawn
Conditions
Kidney Calculi
First Posted Date
2005-07-19
Last Posted Date
2020-11-05
Lead Sponsor
Children's Mercy Hospital Kansas City
Registration Number
NCT00120731
Locations
🇺🇸

The Children's Mercy Hospital, Kansas City, Missouri, United States

Phase III Randomized, Double-Blind Study of Potassium Phosphate Vs Potassium Citrate for Absorptive Hypercalciuria

Phase 3
Completed
Conditions
Hypercalciuria
Kidney Calculi
First Posted Date
1999-10-19
Last Posted Date
2005-06-24
Lead Sponsor
National Center for Research Resources (NCRR)
Target Recruit Count
300
Registration Number
NCT00004284
© Copyright 2025. All Rights Reserved by MedPath